| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Argireline |
阿基瑞林 |
616204-22-9 |
详细
|
| Rosuvastatin methyl ester |
瑞舒伐他汀甲酯. |
147118-40-9 |
详细
|
| 4-Chloromethyl-5-
meth-yl-1,3-dioxol-
2-one |
4-氯甲基-5-甲基-1,3-二氧杂环戊烯-2-酮 |
80841-78-7 |
详细
|
| Ethyl 4-(1-hydroxy-1-methyl-ethyl)-2-propyl-
imidazole-5-
carboxylate |
4-(1-羟基-1-甲基乙基)-2-丙基-1H-咪唑-5-羧酸乙酯 |
144689-93-0 |
详细
|
| Methyl 4'-bromomethyl biphenyl-2-carboxylate |
4'-溴甲基-2-甲酸甲酯联苯 |
114772-38-2 |
详细
|
| 2-n-Propyl-4-methyl-6-(1-methylbenzimi-
dazole-2-yl)benz-
imidazole |
2-正丙基-4-甲基-6-(1'-甲基苯并咪唑-2-基)苯并咪唑 |
152628-02-9 |
详细
|
| Valsartan methyl ester |
缬沙坦甲酯 |
137863-17-3 |
详细
|
| Silodocin P-1 oxalate |
西洛多辛氰基物草酸盐 |
|
详细
|
| Rabamipide Na |
瑞巴派特钠 |
|
详细
|
| Dapoxetine free base |
达泊西汀 |
119356-77-3 |
详细
|
| Tadanafil P-1 |
(1R,3R)-1-(1,3-苯并二氧戊环-5-基)-2-(氯乙酰基)-2,3,4,9-四氢-1H-吡啶并[3,4-B]吲哚-3-羧酸甲酯 |
171489-59-1 |
详细
|
| Dantrolene free base |
丹曲林 |
85008-71-5 |
详细
|
| Varenicline free base |
伐伦克林游离碱 |
249296-44-4 |
详细
|
| N-(4-cyanophenyl)-
glycine |
N-(4-氰基苯基)甘氨酸 |
42288-26-6 |
详细
|
| Ethyl N-[3-amino-4-(methylamino)benzoyl]-N-
pyridin-2-yl-beta-
alaninate |
N-[4-甲胺基-3-氨基苯酰基]-N-2-吡啶基- -丙氨酸乙酯 |
212322-56-0 |
详细
|
| Ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1-
methyl-1H-benz-
imidazol-5-yl)-
carbonyl]-N-pyridin-
2-yl-beta-alaninate |
3-[[[2-[[(4-氰基苯基)氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]吡啶-2-基氨基]丙酸乙酯 |
211915-84-3 |
详细
|
| (S)-2,3-Dimethyl-3-((
triethylsilyl)oxy)butan-1-ol |
(S)-2,3 - 二甲基-3 –((三乙基甲硅烷基)氧基)丁-1 - 醇 |
957997-83-0 |
详细
|
| (S)-3-(methoxymetho-xy)-2,3-dimethylbutan-1-ol |
(S)-3 –(甲氧基甲基)-2,3 –二甲基丁- 1 - 醇 |
1217719-34-0 |
详细
|
| (R)-(2,3-dimethyl-3-((
triethylsilyl)
oxy)butyl)-
diphenylphosphine oxide |
(R)?-(2,3 - 二甲基-3 -((三乙基甲硅烷基)氧基)丁基)二苯基氧化膦 |
1227926-70-6 |
详细
|
| (R)-(2,3-dimethyl-3-
butyl)diphenyl
phosphineoxide |
(R)?-(3 -(甲氧基甲氧基)-2,3 -二甲基丁基)二苯基氧化膦 |
|
详细
|
| (2S)-2-((1R,3aR,7aR)-4-((tert-butyldimethylsilyl)oxy)-7a-methyloctahydro-1H-inden-1-yl)propan-1-ol |
(2S)-2 – ((1R,3aR,7aR)-4 – ((叔丁基二甲基甲硅烷基)氧基)-7a-甲基八氢-1H-茚-1-基)丙-1-醇 |
215509-33-4 |
详细
|
| (1R,3aR,7aR)-1-((2R,5S,E)-6-(methoxy
methoxy)-5,6-dimethylhept-3-en-2-yl)-7a-
methylhexahydro- 1H-inden-4(2H)-one |
(1R,3aR,7aR)-八氢-1-[(1R,2E,?4S)-5-(甲氧基甲氧基)-1,4,5-三甲基-2-己烯-1-基]-7a-甲基-4氢-茚-4-酮 |
100858-26-2 |
详细
|
| (1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl-6- ((triethylsilyl)oxy)hept-3-en-2-yl)-7a-methyl hexahydro-1H- inden-4(2H)-one |
(1R,3aR,7aR)-1-((2R,5S,E)-5,6-二甲基-6-?(三乙基硅氧基) 庚烷-3-烯-2-基)-7a- 甲基六氢-1氢-茚 4(2氢)-酮 |
950586-26-2 |
详细
|
| 2-((3R,5R)-3,5-bis((
tert-butyldimethyl
silyl)-oxy) cyclohexylidene)
ethanol |
2-(3R,5R)-3,5 - 双((叔丁基二甲基甲硅烷基)氧基)亚环己基)乙醇 |
139356-37-9 |
详细
|
| (2-((3R,5R)-3,5-bis((
tert-butyldimethyl-
silyl)oxy)cyclohexyl-
idene)ethyl)diphenylphosphine oxide |
(2 –((3R, 5R)-3,5 - 双((叔丁基二甲基甲硅烷基)氧基)亚环己基)乙基)二苯基氧化膦 |
139356-39-1 |
详细
|
| ATB-1 |
2-氟-4-甲氧基-1-异丙基苯 |
1262414-96-9 |
详细
|
| ATB-4 |
2-氯-5-(三氟甲基)苄基溴 |
237761-77-2 |
详细
|
| Diallyl bisphenol A |
2,2'-二烯丙基双酚 |
1745-89-7 |
详细
|
| 5,6-Dihydroxyindole |
5,6-二羟基吲哚 |
3131-52-0 |
详细
|
| 5,6-Dihydroxy-1H-Indole-2-Carboxylic Acid |
5,6-二羟基-1H-吲哚-2-羧酸 |
4790-08-3 |
详细
|
| Methyl 5,6-dihydroxy-1H-indole-2-Carboxylate |
5,6-二羟基-1H-吲哚-2-羧酸甲酯 |
10131-14-3 |
详细
|
| 2,2-dimethyl-5H-1,3-dioxol[4,5-f]indole |
2,2-二甲基- 5H-[1,3]-二恶英[4,5-f]吲哚 |
437757-21-6 |
详细
|
| (E)-methyl 3-(2,2-dimethylbenzo[d][1,3]dioxol-5-yl)acrylate |
(E)-甲基-3-(2,2-甲基苯并[d][1,3]二氧基-5基-丙烯酸酯 |
2187481-85-0 |
详细
|
| Cis-Sertraline-D-Madenlic acid |
Sertraline HCl related substance舍曲林相关物质 |
|
详细
|
| Sitagliptin impurity 1~5 |
Sitagliptin related substance西格列汀相关物质 |
1217809-78-3 |
详细
|
| Methyl caffeate |
咖啡酸甲酯 |
67667-67-8 |
详细
|
| Quinic acid |
右旋奎宁酸 |
77-95-2 |
详细
|
| Phenethyl caffeate |
咖啡酸苯乙酯 |
104594-70-9 |
详细
|
| ATB-9 |
安塞曲匹中间体 |
875444-10-3 |
详细
|
| Caffeic acid |
咖啡酸 |
331-39-5 |
详细
|
| Landiolol impurity 1 |
盐酸兰地洛尔杂质-1 |
1253907-85-5 |
详细
|
| Landiolol impurity 2 |
盐酸兰地洛尔杂质-2 |
1253907-81-1 |
详细
|
| Landiolol impurity 3 |
盐酸兰地洛尔杂质-3 |
1253907-83-3 |
详细
|
| Dabigatran amidine HCl |
达比加群脒盐酸盐 |
211914-50-5 |
详细
|
| Indobufen impurity 2 |
吲哚布芬杂质 2 |
36691-02-8 |
详细
|
| Indobufen impurity 3 |
吲哚布芬杂质 3 |
203313-55-7 |
详细
|
| Sarpogrelate HCl |
沙格雷酯盐酸盐 |
125926-17-2 |
详细
|
| BP984 |
1-(二甲基氨基)-3-[2-[2-(3-甲氧基苯基)乙基]苯氧基]-2-丙醇盐酸盐 |
135261-74-4 |
详细
|
| Crisaborole impurity 1 |
克立硼罗杂质 1 |
906673-43-6 |
详细
|
| Crisaborole impurity 2 |
克立硼罗杂质 2 |
1187188-59-5 |
详细
|
| Crisaborole impurity 3 |
克立硼罗杂质 3 |
888967-63-3 |
详细
|
| Sitagliptin impurity 1 |
西格列汀杂质 1 |
1345822-87-8 |
详细
|
| Sitagliptin impurity 2 |
西格列汀杂质 2 |
1345822-86-7 |
详细
|
| Sitagliptin impurity 3 |
西格列汀杂质 3 |
823817-58-9 |
详细
|
| Sitagliptin impurity 4 |
西格列汀杂质 4 |
823817-57-8 |
详细
|
| Sitagliptin impurity 5 |
西格列汀杂质 5 |
837430-15-6 |
详细
|
| Lesinurad sodium |
雷西纳德钠 |
1151516-14-1 |
详细
|
| de-bromo Lesinurad |
雷西纳德脱溴杂质 |
1533519-93-5 |
详细
|
| Benserazide HCl |
盐酸苄丝肼 |
14919-77-8 |
详细
|
| Benserazide P-1 |
苄丝肼 P-1 |
1353749-74-2 |
详细
|
| Silodosin P-1 oxalate |
西洛多辛P-1草酸盐 |
1883697-83-3 |
详细
|
| Silodosin impurity 2 |
西洛多辛杂质 2 |
175870-21-0 |
详细
|
| Rebamipide sodium salt |
瑞巴派特钠盐 |
|
详细
|
| Rebamipide meta-Cl impurity |
瑞巴派特间氯异构体 |
90098-05-8 |
详细
|
| Roxatidine impurity 1 |
罗沙替丁杂质 1 |
73279-04-6 |
详细
|
| Roxatidine impurity 3 |
罗沙替丁杂质 3 |
78274-00-7 |
详细
|
| Roxatidine impurity 4 |
罗沙替丁杂质 4 |
97900-87-3 |
详细
|
| Elagolix impurity 1 |
噁拉戈利杂质 1 |
2248628-93-3 |
详细
|
| Elagolix impurity 3 |
噁拉戈利杂质 3 |
2375499-61-7 |
详细
|
| Erdosteine |
厄多司坦 |
84611-23-4 |
详细
|
| Ilaprazole |
艾普拉唑 |
172152-36-2 |
详细
|
| Ilaprazole intermediate P-3 |
艾普拉唑中间体P-3 |
172152-53-3 |
详细
|
| Ilaprazole impurity 1 |
艾普拉唑杂质 1 |
172152-37-3 |
详细
|
| Ilaprazole impurity 3 |
艾普拉唑杂质 3 |
84445-90-9 |
详细
|
| Ilaprazole impurity 4 |
艾普拉唑杂质 4 |
1018229-53-2 |
详细
|
| Fexuprazan P-4 |
非苏拉赞 P-4 |
1902955-29-6 |
详细
|
| Fexuprazan P-1 |
非苏拉赞 P-1 |
1902955-31-0 |
详细
|
| N-Bn Tegoprazan parent nucleus |
N-苄基特戈拉赞母核 |
1640981-20-9 |
详细
|
| N-Ts Tegoprazan P-1 |
N-对甲苯磺酰基特戈拉赞 P-1 |
4942485-42-9 |
详细
|
| N-Bn Tegoprazan P-1 |
N-苄基特戈拉赞 P-1 |
|
详细
|
| R-Tegoprazan isomer |
R-特戈拉赞异构体 |
942195-56-4 |
详细
|
| Vonoprazan Fumarate |
富马酸沃诺拉赞 |
1260141-27-2 |
详细
|
| Deoxycholic acid P-1 |
去氧胆酸 P-1 |
181270-68-8 |
详细
|
| Deoxycholic acid impurity 1 |
去氧胆酸杂质 1 |
|
详细
|
| Deoxycholic acid impurity 2 |
去氧胆酸杂质 2 |
69519-35-3 |
详细
|
| Deoxycholic acid impurity 3 |
去氧胆酸杂质 4 |
|
详细
|
| Sodium Picosulfate impurity A |
匹可硫酸钠杂质A |
32500-19-9 |
详细
|
| Diclofenac Epolamine impurity 2 |
双氯芬酸依泊胺杂质 2 |
13625-57-5 |
详细
|
| Diclofenac Epolamine impurity 4 |
双氯芬酸依泊胺杂质 4 |
127792-23-8 |
详细
|
| Diclofenac Epolamine impurity 6 |
双氯芬酸依泊胺杂质 6 |
42088-52-8 |
详细
|
| Diclofenac Epolamine impurity 7 |
双氯芬酸依泊胺杂质 7 |
172494-87-0 |
详细
|
| Pranoprofen P-2 |
普拉洛芬 P-2 |
146330-68-9 |
详细
|
| Pranoprofen impurity B |
普拉洛芬杂质B |
52549-22-1 |
详细
|
| Raloxifene HCl P-1 |
甲基雷洛昔芬 |
84541-36-6 |
详细
|
| 5-amino-2-(propylthio)pyrimidin-4-ol |
|
|
详细
|
| GSK-2110183C impurity M14 |
福瑞赛替杂质M14 |
|
详细
|
| Oxobutanedioic acid |
草酰乙酸 |
328-42-7 |
详细
|
| GDC-0276 |
GDC0276 |
1494581-70-2 |
详细
|
| Mefatinib |
迈华替尼 |
1417695-74-9 |
详细
|
| GDC-0310 intermediate 1 |
GDC-0310中间体1 |
1788072-29-6 |
详细
|
| 1-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione |
1-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione |
69998-14-7 |
详细
|
| JH-VIII-157-02 |
化合物 T15612 |
1639422-97-1 |
详细
|
| Glimepiride methyl ester |
格列美脲甲基酯杂质 |
119018-30-3 |
详细
|
| 4-chloro-5-nitro-2-(propylthio)pyrimidine |
替格瑞洛杂质15 |
2518331-26-3 |
详细
|
| Oseltamivir degradation impurity 1 |
奥司他韦降解杂质 1 |
|
详细
|
| 6-chloro-3-isopropylpyrimidine-2,4(1H,3H)-dione |
马伐凯泰中间体 |
887581-47-7 |
详细
|
| GSK-2110183C |
福瑞赛替 |
1047644-62-1 |
详细
|
| Mavacamten
MYK461
(S)-3-isopropyl-6-((1-phenylethyl)amino)pyrimidine-2,4(1H,3H)-dione |
玛伐凯泰 |
1642288-47-8 |
详细
|
| 1,1'-(4-(ethylamino)-6-hydroxy-1,3-phenylene)bis(ethan-1-one) |
|
79324-49-5 |
详细
|
| (S)-(4-Fluorophenyl)(2-(pyrrolidin-2-yl)thiazol-4-yl)methanone hydrochloride |
LCL-161前体-C6 |
1263876-35-2 |
详细
|
| GSK-2110183C impurity d-M14 |
福瑞赛替杂质氘代M14 |
|
详细
|
| MK-1755 intermediate 2 |
MK-1755中间体2 |
2007908-48-5 |
详细
|
| 4-methoxy-5-nitro-2-(propylthio)pyrimidine |
|
2514951-26-7 |
详细
|
| GDC-0310 intermediate 2 |
GDC-0310中间体2 |
1788072-30-9 |
详细
|
| GDC-0310 intermediate 4 |
GDC-0310中间体4 |
2448100-15-8 |
详细
|
| d-Mefatinib |
氘代迈华替尼 |
|
详细
|
| L-Threonine, N-(4-ethynylbenzoyl)-, methyl ester |
CHIR090-中间体1 |
728878-24-8 |
详细
|
| Oseltamivir degradation impurity 2 |
奥司他韦降解杂质 2 |
|
详细
|
| MK-1755 intermediate 4 |
1,2-二氢-1-[6-(1-羟基-1-甲基乙基)-2-吡啶]-6-(甲基硫代)-2-(2-丙烯-1-基)-3H-吡唑并[3,4-D]嘧啶-3-酮 |
955369-56-9 |
详细
|
| 4-aMino-3-Methoxy-N-(1-Methylpiperidin-4-yl)benzaMide |
4-氨基-3-甲氧基-N-(1-甲基哌啶-4-基)苯甲酰胺 |
876126-60-2 |
详细
|
| GDC-0310 intermediate 3 |
|
|
详细
|
| Raloxifene impurity 1 |
雷洛昔芬杂质 1 |
84541-37-7 |
详细
|
| N-(2,4-diacetyl-5-hydroxyphenyl)acetamide |
|
79324-44-0 |
详细
|
| 1,1'-(4-(allyloxy)-6-(ethylamino)-1,3-phenylene)bis(ethan-1-one) |
乙酮, 1,1'-[4-(乙基氨基)-6-(2-丙烯基OXY)-1,3-苯基ENE]双- (9CI) |
79324-50-8 |
详细
|
| CHIR090 |
CHIR 090 |
728865-23-4 |
详细
|
| LCL161 |
LCL161 |
1005342-46-0 |
详细
|
| GSK-2110183C intermediate |
福瑞赛替羧酸中间体 |
1047630-61-4 |
详细
|
| Iodonitrotetrazolium chloride |
碘硝基氯化四氮唑蓝 |
146-68-9 |
详细
|
| MK-1755 intermediate 1 |
1-烯丙基肼甲酸叔丁酯 |
21075-86-5 |
详细
|
| Carbamic acid, N-?[(1S)?-?1-?cyclohexyl-?2-?[(2S)?-?2-?[4-?(4-?fluorobenzoyl)?-?2-?thiazolyl]?-?1-?pyrrolidinyl]?-?2-?oxoethyl]?-?, 1,?1-?dimethylethyl ester |
LCL-161前体-C7 |
1005342-80-2 |
详细
|
| L-Threonine, N-[4-[2-[4-(4-morpholinylmethyl)phenyl]ethynyl]benzoyl]-, methyl ester |
CHIR090-中间体1 |
728878-12-4 |
详细
|
| BI-2536 parent nucleus |
(7R)-2-氯-8-环戊基-7-乙基-7,8-二氢-5-甲基-6(5H)-蝶啶酮 |
755039-55-5 |
详细
|
| Glimepiride Cis isomer |
格列美脲顺势异构体 |
684286-46-2 |
详细
|
| MK-1755 |
MK-1775 |
955365-80-7 |
详细
|
| MK-1755 intermediate 3 |
2-烯丙基-6-(甲基硫代)-1H-吡唑并[3,4-D]嘧啶-3(2H)-酮 |
955368-90-8 |
详细
|
| Raloxifene impurity 2 |
雷洛昔芬杂质 2 |
173773-26-7 |
详细
|
| 1,1'-(4-(ethylamino)-6-hydroxy-5-propyl-1,3-phenylene)bis(ethan-1-one) |
乙酮, 1,1'-[4-(乙基氨基)-6-羟基-5-丙基-1,3-苯基ENE]双- (9CI) |
79324-51-9 |
详细
|
| Testosterone Tridecanoate |
睾酮13烷酸酯 |
488836-58-4 |
详细
|
| GDC-0310 |
|
1788063-52-4 |
详细
|
| 1,1'-(4-amino-6-hydroxy-1,3-phenylene)bis(ethan-1-one) |
|
79324-45-1 |
详细
|